Introduction. Acinetobacter baumannii is a Gram-negative nosocomial pathogen that has the capacity to develop resistance to all classes of antimicrobial compounds. However, very little is known regarding its susceptibility to biocides (antiseptics and disinfectants) and capacity to form biofilms, particularly for Malaysian isolates. Aim. To determine the susceptibility of A. baumannii isolates to commonly-used biocides, investigate their biofilm-forming capacities and the prevalence of biocide resistance and biofilm-associated genes. Methodology. The minimum inhibitory concentration (MIC) values of 100 A. baumannii hospital isolates from Terengganu, Malaysia, towards the biocides benzalkonium chloride (BZK), benzethonium chloride (BZT) and chlorhexidine digluconate (CLX), were determined by broth microdilution. The isolates were also examined for their ability to form biofilms in 96-well microplates. The prevalence of biocide resistance genes qacA, qacE and qacE1 and the biofilm-associated genes bap and abaI were determined by polymerase chain reaction (PCR). Results. Majority of the A. baumannii isolates (43%) showed higher MIC values (> 50 µg/mL) for CLX than for BZK (5% for MIC > 50 µg/mL) and BZT (9% for MIC > 50 µg/mL). The qacE1 gene was predominant (63%) followed by qacE (28%) whereas no isolate was found harbouring qacA. All isolates were positive for the bap and abaI genes although the biofilm-forming capacity varied among the isolates. Conclusion. The Terengganu A. baumannii isolates showed higher prevalence of qacE1 compared to qacE although no correlation was found with the biocides' MIC values. No correlation was also observed between the isolates' biofilm-forming capacity and the MIC values for the biocides.
Introduction
Acinetobacter baumannii, a Gram-negative, nonfermentative coccobacilli, is a predominant cause of nosocomial infection and can survive on inanimate surfaces for long periods of time. It has gained prominence in the past few decades due to its ability to acquire and develop resistance to all classes of antibiotics over a relatively short period of time [1, 2] . A. baumannii is estimated to be responsible for about 10% of nosocomial infections and has been identified as a cause of increased mortality of up to 80% in neonates, particularly in intensive care units [3, 4] . In Malaysia, A. baumannii is the most prevalent nosocomial pathogen in most intensive care units [5] [6] [7] [8] .
Both the hospital environment and colonized patients have been shown to be major reservoirs for A. baumannii infections [9], thereby making the management and effective control of A. baumannii a challenge for hospital physicians and authorities. Biocides, including disinfectants and antiseptics, play a crucial role in the prevention of nosocomial transmission of infectious pathogens with the biguanide compound, chlorhexidine gluconate (CLX), and the quaternary ammonium compounds, benzethonium chloride (BZT) and benzalkonium chloride (BZK), being among the more extensively used [10] . However, extensive use of these biocides in hospitals had led to concerns on the development of resistance and the spread of biocide resistance genes [10, 11] , mirroring the spread of antibiotic resistance in pathogenic bacteria. Despite the importance of biocide resistance, there is a dichotomy in the number of published papers regarding reduced susceptibilities to biocides when compared with the much larger volume of publications on antibiotic resistance [12] . In Malaysia, there has only been a single published paper so far that reported on antiseptic resistance in A. baumannii and its associated resistance genes [13] .
Resistance to antiseptics and disinfectants in pathogenic bacteria are largely mediated by efflux proteins encoded by qac genes. The qacA/B genes encode for proteins of the major facilitator superfamily (MFS) whereas qacC, qacE, qacF, qacG, qacH, qacJ and qacZ encode for efflux proteins of the small multidrug resistance (SMR) family [14] . The qacE gene and its functionally active deletion derivative designated qacE1, are mainly found in Gram-negative bacteria, including A. baumannii [11] . These genes are commonly located on mobile elements such as integrons and transposons as well as transmissible plasmids, thus facilitating their spread [15] .
The ability to form biofilms is one of the important virulence factors that enable A. baumannii to survive in the harsh hospital environment by affording the bacteria greater protection against antimicrobials and survival in dry and desiccated conditions [16] . A. baumannii is known to form biofilm communities on most abiotic surfaces and thus contributes to medical-deviceassociated infections [17] . Biofilm formation is a complex process involving a repertoire of genes and although several factors that contribute to biofilm formation appear to be strain-dependent, some common factors have been identified [16] [17] [18] . A. baumannii produce biofilm-associated proteins (Bap), which are large surface-exposed proteins secreted through a type I secretion system (T1SS), and plays an important role in cell-cell adhesion and the development of higher order structures on medically-relevant materials [17, 19] . Biofilm formation in A. baumannii is also under the control of an auto-inducing quorum sensing molecule (acyl-homoserine lactone) that is biosynthesized by the abaI-encoded autoinducer synthase [16, 20] .
We have previously characterised A. baumannii isolates from the main tertiary hospital in the east coast state of Terengganu in Peninsular Malaysia for their antimicrobial resistance profiles and carriage of carbapenem resistance genes [21, 22] . Here, we examine a sample of these isolates obtained from 2011 -2016 for their susceptibilities to the biocides CLX, BZT and BZK and determine the prevalence of the biocide resistance genes qacA, qacE and qacE. We also investigate the biofilm-forming capacities of these A. baumannii isolates and their carriage of the biofilmassociated genes bap and abaI. This would give us a more well-informed picture of the Terengganu A. baumannii isolates, filling in the gap in our knowledge as data regarding biocide susceptibility and biofilm capability of A. baumannii from Malaysia are scarce.
Methodology

Bacterial strains
A total of 100 A. baumannii isolates used in this study were collected from the Microbiology Laboratory, Department of Pathology, Hospital Sultanah Nur Zahirah (HSNZ), Kuala Terengganu, Terengganu in 2011 (n = 6), 2012 (n = 14), 2015 (n = 30) and 2016 (n = 50). The isolates were identified as [24] , i.e., resistance to three or more classes of antimicrobials; ***Interpretation of OD540 values: < 0.3 = weak; between 0.3 -1.0 = moderate; > 1.0 = strong. Acinetobacter spp. by the hospital laboratory and validated as A. baumannii by rpoB sequencing as previously described [22] . Details of the source for the isolates are in Supplementary Table 1 . There were fewer isolates from 2011 and 2012 due mainly to the intermittent collection of isolates in those years and a few them were unable to be revived from frozen stock cultures. Isolates from 2015 and 2016 were randomly chosen from our collection of A. baumannii isolates obtained from HSNZ during those two years. HSNZ is the main public tertiary referral hospital in the state of Terengganu, Malaysia and has a total of 821 beds and 29 wards with a 20-bed intensive care unit (ICU). Ethical approval for this study was obtained from the Medical Research & Ethics Committee of the Malaysian Ministry of Health's National Medical Research Register (approval no. NMRR-14-1650-23625-IIR).
Determination of MIC values for antiseptics
The antiseptics used in this study were the quaternary ammonium compounds, benzalkolium chloride (BZK) and benzethonium chloride (BZT) as well as the biguanide compound, chlorhexidine digluconate (CLX), which were purchased from Sigma-Aldrich (St. Louis, USA). A stock solution of the relevant antiseptic (100 mg/l) was prepared in sterile deionized water and stored at 4ºC. The minimum inhibitory concentration (MIC) of each antiseptic was determined using the broth microdilution method in sterile, disposable 96-well microplates as per the Clinical and Laboratory Standards Institute guidelines [23] . In the absence of any standard breakpoints for antiseptics against Acinetobacter spp., we decided to use concentrations that were modified from those reported by Babaei et al. [13] . Into wells one to twelve of a 96-well microplate, a 50 µL bacterial suspension in LB broth at 0.5 McFarland standard (approximately 1.5 × 10 8 CFU/mL) was added. Subsequently, 50 µL of the stock antiseptic solution was added into well one, mixed with the bacterial suspension, after which 50 µL was then transferred to the next well and continued until the last well of that row. This would lead to the microplate row containing antiseptic concentrations that ranged from 50 to 0.024 µg/mL. For each test plate, two antiseptic-free controls were prepared: one containing 100 µL medium alone (acting as a sterility control) and another with 50 µL medium plus 50 µL of bacterial inoculum (as a growth control). The microplate was covered and incubated at 37ºC for 16 -20 hours after which the turbidity was measured at 625 nm in a microplate reader. The MIC was defined as the lowest concentration of the antiseptic that inhibits visible growth of the tested A. baumannii isolate as measured by the OD625 values compared with the controls [12] .
Antimicrobial susceptibility profiles
Susceptibility of the A. baumannii isolates to carbapenems [imipenem (10 µg) and meropenem (10 µg)] and 11 other antimicrobials [i.e., amikacin (30 µg), gentamicin (10 µg), ciprofloxacin (5 µg), piperacillintazobactam (100/10 µg), ticarcillin-clavulanate (75/10 µg), ampicillin-sulbactam (10/10 µg), cefotaxin (30 µg), ceftriaxone (30 µg), ceftazidime (30 µg), cefepime (30 µg), and tetracycline (30 µg)] was determined by the disc diffusion method in accordance with the Clinical and Laboratory Standards Institute (CLSI) guidelines [23] . Isolates that were resistant to three or more classes of antimicrobials were categorised as multidrug resistant (MDR) following the proposed criteria of the joint initiative of the European Centre for Disease Prevention and Control (ECDC) and the United States Centers for Disease Prevention and Control (CDC) [24] .
Biofilm Assay
The capacity of the A. baumannii isolate to form biofilms was assayed following the method described by King et al. [25] . Each A. baumannii isolate was inoculated in 10 mL LB broth and incubated overnight at 37ºC. A 50 µL aliquot of the overnight culture was added into 50 µL LB broth in the well of a 96-well microplate and further incubated at 37ºC for 16 -20 hours. The assay was performed in triplicates for each A. baumannii isolate. Following overnight incubation, the wells of the plate were washed four times with deionized H2O, 100 µL of 0.1% crystal violet was added to each well and incubated at room temperature for 30 min. The plate was then washed four times with deionized H2O before adding 200 µL 95% ethyl alcohol after which 125 µL of the sample was transferred to a new plate and the absorbance measured at 540 nm using a microplate reader. A reading of < 0.3 was considered as weak biofilm formation, between 0.3 -1.0 was moderate, while readings of > 1.0 was considered as strong.
Genomic DNA extraction and polymerase chain reaction (PCR) of target genes
Genomic DNA from the A. baumannii isolates were extracted using the MasterPure DNA Purification Kit (Epicentre, Madison, WI, USA) according to the manufacturer's instructions. The genomic DNA obtained was stored at -20ºC until used. PCR was used to screen all A. baumannii isolates for the presence of the quaternary ammonium compound resistance genes qacA, qacE and qacΔE1, and the biofilm-associated genes bap and abaI. Each PCR reaction consist of 25 µL of Taq DNA polymerase master mix RED 2.0x (Ampliqon, Odense, Denmark) to which was added 21 µL sterile distilled water and 1 µL each of the forward and reverse primers (at 20 nM each) and 2 µL genomic DNA (~50 ng/µL) to make up a total volume of 50 µL. The primer sequences and PCR conditions are listed in the Supplementary Table 2 . The PCR-amplified products were detected by electrophoresis on a 1.5% agarose gel which was then stained with ethidium bromide and visualised under UV illumination in a transilluminator (Uvitek, Cambridge, UK). The amplicons obtained were purified using the GeneJet PCR Purification Kit (ThermoScientific, Waltham, USA) and sequenced using conventional Sanger dideoxy sequencing at a commercial DNA sequencing service provider (Apical Scientific, Seri Kembangan, Malaysia) for validation. DNA sequence data was analysed by BLAST at https://blast.ncbi.nlm.nih.gov/Blast.cgi.
Statistical analyses
SPSS version 23.0 was used for the statistical analyses of the data obtained. Descriptive statistics were used to describe the differences in variables. Frequency and percentages were applied to characterise the prevalence of antiseptic resistance and biofilmassociated genes from A. baumannii that were isolated from different wards of the hospital. Chi-square was applied to determine correlations between the carriage of antiseptic resistance genes and observable reduced antiseptic susceptibility as well as between the carriage of biofilm-associated genes and extent of biofilm formation. P values < 0.05 were considered as statistically significant.
Results
A significant proportion of the 100 A. baumannii isolates from HSNZ, Terengganu, showed higher MIC values (> 50 g/mL) for CLX (43%) as compared to BZT (9%) and BZK (5%) (see Supplementary Table 1 for the full results of the 100 isolates). Slightly over 50% of the A. baumannii isolates had an MIC value of 12.5 g/mL for BZK whereas for BZT, the isolates mainly displayed MIC values of 12.5 g/mL (36%) and 25 g/mL (34%) (Figure 1 ). When the results were analysed according to the year of isolation, the number of A. baumannii isolates with a high CLX MIC of > 50 g/mL showed a decline from a high of 57.1% in 2012 to 38.8% in 2016 ( Figure 2 ). Isolates with a lower CLX MIC value of 6.25 g/mL also appeared in 2015 and 2016. In contrast, the prevalence of isolates with high MIC values for BZT (i.e., 25 g/mL and > 50 g/mL) showed a steady increase from 2011 to 2016 with isolates displaying an MIC value of 50 g/mL only appearing in 2016 ( Figure 3A) . Likewise, an increase in the prevalence of isolates with higher MIC values for BZK was also observed with those showing an MIC value of > 50 g/mL also appearing only in 2016 ( Figure 3B ). However, it should be noted that the number of A. baumannii isolates from 2011 (n = 6) and 2012 (n = 14) were smaller as compared to 2015 (n = 30) and 2016 (n = 50), and thus any comparisons should be made with caution. The qacE1 gene was predominant (63%) followed by qacE (28%) whereas none of the HSNZ A. baumannii isolates harboured the qacA gene. No significance (p > 0.05) was observed between carriage of either the qacE1 or qacE gene with high MIC values for CLX, BZK and BZT. Isolates such as AC1626 and AC1629, which were positive for both qacE1 and qacE, yielded CLX MIC of 25 g/mL and BZK and BZT MIC values of 12.5 g/mL (Table 1) . Conversely, isolates such as AC1618 and AC1624, which were negative for both qacE1 and qacE, showed higher MIC values for CLX (> 50 g/mL) as well as BZT and BZK (either 25 g/mL or > 50 g/mL) ( Table 1) .
All 100 A. baumannii isolates were positive for the biofilm-associated genes bap and abaI. However, the capacity to form biofilms (i.e., categorized as weak, moderate or strong) varied among the isolates with the majority of the isolates forming either moderate (n = 51/100) or weak (n = 45/100) biofilms and only a minority (n = 4/100) forming strong biofilms. Three of the four isolates forming strong biofilms were obtained from the ICU; however, no correlation was observed between the ward where the isolates were obtained and their biofilm-forming capacity. Out of 34 A. baumannii isolates that were obtained from the ICUs, 16 (or 47%) had moderate biofilm-forming capacity, 15 (or 44%) had weak biofilm-forming capacity and only three (or 8.8%) had strong biofilm-forming capacity. Interestingly, out of the four isolates with strong biofilm-forming ability, three of these displayed CLX MICs of > 50 µg/mL whereas the MICs for BZT and BZK ranges from 12.5 -25 µg/mL. The remaining A. baumannii isolate with a strong biofilm-forming capacity, AC1642, showed a CLX MIC of 25 µg/mL (Table 1) . Nevertheless, beyond these four isolates, no correlation was observed between the isolates' biofilmforming capacity and the MIC values for the biocides. A. baumannii AC1605, for instance, had CLX and BZT MIC values of > 50 µg/mL but displayed only weak biofilm-forming ability ( Table 1) .
Discussion
There is a paucity of published data regarding biocide susceptibility in A. baumannii, particularly from Malaysia. To our knowledge, there has only been a single paper so far that was published on A. baumannii isolates obtained in 2012 -2013 from a tertiary care teaching hospital in the capital city of Malaysia, Kuala Lumpur [13] . In that paper, high prevalence (72.95%) of qacE was reported among the A. baumannii isolates with no qacA detected [13] . Although in this study, no qacA was also detected in the HSNZ A. baumannii isolates from 2011 -2016, the prevalence of qacE was much lower in comparison, at 28%. The most prevalent biocide resistance gene in the HSNZ isolates was qacΔE1 (at 63%) but Babaei et al.
[13] did not screen for the presence of this gene in their collection of A. baumannii isolates. The predominance of qacΔE1 was recently reported in carbapenem resistant A. baumannii isolates (96.07%) from China [11] , and here the prevalence of qacE (at 31.37%) was similar to that of our HSNZ isolates. However, Liu et al. also reported the carriage of qacA in some of their Chinese A. baumannii isolates [11], albeit at a lower prevalence (13.72%), and this was similarly reported in isolates from Saudi Arabia (16.7% prevalence) [12] . This was very much in line with previous findings which showed that qacA is found mainly in Gram-positive bacteria as compared to Gram-negatives [14] . The Saudi study also reported similar prevalence for qacE (i.e., at 33.3%) in their 24 A. baumannii isolates that were obtained in 2015, but like Babaei et al. [13] , the researchers did not screen for the presence of qacΔE1 [12] .
Currently, there are no standard breakpoints for biocides such as those for antibiotics in A. baumannii and many other pathogens. There are also differences in the methods used for obtaining the MIC values for the biocidal agents. Here, we tried to utilize the same method (broth microdilution) used by the other Malaysian study [13] such that there will be a basis for data comparison. However, we had to modify the concentrations of biocides used in this study as we consistently obtained much higher MIC values for all the biocides tested. Babaei et al. reported CLX MIC values that ranged from 0.2 -0.6 µg/mL for their qacEpositive isolates and even lower MIC values of 0.04 -0.3 µg/mL for qacE-negative isolates [13] . In contrast, the lowest MIC value for CLX that was obtained in this study was 6. 25 [26] . Likewise, for the quaternary ammonium compounds BZT and BZK, our HSNZ A. baumannii isolates showed much higher MIC values than earlier reported by Babaei et al.
[13] but the BZK values were more similar to the MIC ranges reported by Liu et al. [11] , Vijayakumar et al.
[12] and Fernández-Cuenca et al. [26] (these studies did not report on BZT). These variations reaffirm the pressing need for standardized testing methodologies as well as breakpoint values for biocides.
Our study also corroborates other reports which indicated no correlation between the carriage of biocide resistance genes such as qacE and qacΔE1 with reduced biocide susceptibilities [11] [12] [13] . Nevertheless, Liu et al. reported that in their carbapenem-resistant A. baumannii strains that harboured qacE, a higher MIC for BZK (64 µg/mL) was observed [11], but this was not the case for our HSNZ isolates and also for the isolates from Saudi Arabia [12] . It should be noted that not all the HSNZ A. baumannii isolates used in this study were resistant to carbapenems. Isolates such as AC1608 and AC1621 which were carbapenemsusceptible and negative for qacE showed high MIC for BZK (> 50 µg/mL) whereas isolates such as AB1201 which was carbapenem-resistant and positive for qacE had a much lower MIC for BZK (3.125 µg/mL) (Suppplementary Table 1 ). Clearly further research needs to be carried out to determine the genetic basis for reduced biocide susceptibility in A. baumannii as the carriage of some of these genes did not appear to be a significant factor for the development of biocide resistance.
Large variations in the biofilm-forming capacity of clinical A. baumannii isolates have been previously reported [25, 27, 28] and the results of this study corroborated this. Various gene loci have been implicated in the formation of biofilms in A. baumannii (see review by Longo et al. [29] ). In this study, we examined the carriage of two of these genetic determinants, bap and abaI, and found that all 100 isolates that we screened by PCR harboured these two genes. However, it should be noted that the PCR primers only detect the conserved part of these genes and whether these genes are intact and fully functional in the isolates screened is not known. This is particular pertinent for bap as the gene is a large (approximately 16 kb in size), repetitive locus with variations in both gene size as well as the molecular mass of the Bap protein produced [30] . Inconsistencies in bap gene prevalence as determined by PCR and the expression of the Bap protein have been reported [30] . Although biofilm is recognized as a contributing factor to the pathogenicity of A. baumannii and its capacity to persist in the harsh healthcare environment, a recent study showed that epidemic or outbreak A. baumannii isolates had significantly lower biofilm forming capacity when compared to sporadic isolates [28] . This led the authors to conclude that biofilm formation may not be an important factor for the epidemic spread of A. baumannii [28] . Interestingly, we found that three of the four strong biofilm-producing isolates from HSNZ showed high MIC values for the biocides CLX, BZT and BZK. However, no conclusive correlation was found between the biofilm-forming capacity and the MIC of biocides in the other A. baumannii isolates. In contrast, Hu et al. [28] reported that multidrug resistant (MDR) A. baumannii clinical isolates showed lower biofilm forming capacity as compared to non-MDR isolates. They speculated that in non-MDR isolates, the capacity to form biofilms may play a more important role in their environmental persistence in hospitals thereby placing a selective evolutionary advantage for isolates that developed high biofilm-forming capacity [28] . However, our data is not in support of this as of the four strong biofilm-producing isolates, three were MDR and only one was non-MDR (Table 1) . Nevertheless, further studies need to be carried out to conclusively determine if there are any correlations between the biofilm-forming capacity of A. baumannii isolates and their susceptibilities/resistances to antibiotics as well as biocides.
Conclusion
In conclusion, this study has shown that the Terengganu HSNZ A. baumannii isolates had wide variations in their MIC values for the biocides CLX, BZT and BZK, as well as their biofilm-forming capacities. The qacΔE1 gene is the predominant biocide resistance gene in the HSNZ isolates with no qacA gene detected. All the A. baumannii clinical isolates were positive for the bap and abaI biofilm-associated genes although the biofilm-forming capacities for the isolates were varied. of [20] Reverse CGTACGTCTAGAGTAATGAGTTGTTTTGCGCC
